| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An Understated Comorbidity: The Impact of Homelessness on Traumatic Brain Injury
|
Monsour, M.
|
|
|
20 |
6 |
p. 1446-1456
|
artikel
|
| 2 |
An Understated Comorbidity: The Impact of Homelessness on Traumatic Brain Injury
|
Monsour, M.
|
|
|
20 |
6 |
p. 1446-1456
|
artikel
|
| 3 |
ApoE Mimetic Peptides as Therapy for Traumatic Brain Injury
|
Laskowitz, Daniel T.
|
|
|
20 |
6 |
p. 1496-1507
|
artikel
|
| 4 |
ApoE Mimetic Peptides as Therapy for Traumatic Brain Injury
|
Laskowitz, Daniel T.
|
|
|
20 |
6 |
p. 1496-1507
|
artikel
|
| 5 |
Application of P7C3 Compounds to Investigating and Treating Acute and Chronic Traumatic Brain Injury
|
Sridharan, Preethy S.
|
|
|
20 |
6 |
p. 1616-1628
|
artikel
|
| 6 |
Application of P7C3 Compounds to Investigating and Treating Acute and Chronic Traumatic Brain Injury
|
Sridharan, Preethy S.
|
|
|
20 |
6 |
p. 1616-1628
|
artikel
|
| 7 |
Arterial Glyceryl Trinitrate in Acute Ischemic Stroke After Thrombectomy for Neuroprotection (AGAIN): A Pilot Randomized Controlled Trial
|
Cheng, Zhe
|
|
|
20 |
6 |
p. 1746-1754
|
artikel
|
| 8 |
Arterial Glyceryl Trinitrate in Acute Ischemic Stroke After Thrombectomy for Neuroprotection (AGAIN): A Pilot Randomized Controlled Trial
|
Cheng, Zhe
|
|
|
20 |
6 |
p. 1746-1754
|
artikel
|
| 9 |
Assessing Sustained B-Cell Depletion and Disease Activity in a French Multiple Sclerosis Cohort Treated by Long-Term IV Anti-CD20 Antibody Therapy
|
Freeman, Sean A.
|
|
|
20 |
6 |
p. 1707-1722
|
artikel
|
| 10 |
Assessing Sustained B-Cell Depletion and Disease Activity in a French Multiple Sclerosis Cohort Treated by Long-Term IV Anti-CD20 Antibody Therapy
|
Freeman, Sean A.
|
|
|
20 |
6 |
p. 1707-1722
|
artikel
|
| 11 |
Calpain-2 Inhibitors as Therapy for Traumatic Brain Injury
|
Baudry, Michel
|
|
|
20 |
6 |
p. 1592-1602
|
artikel
|
| 12 |
Calpain-2 Inhibitors as Therapy for Traumatic Brain Injury
|
Baudry, Michel
|
|
|
20 |
6 |
p. 1592-1602
|
artikel
|
| 13 |
Correction: Transforming Drug Development for Neurological Disorders: Proceedings from a Multidisease Area Workshop
|
Stephenson, Diane
|
|
|
20 |
6 |
p. 1893
|
artikel
|
| 14 |
Correction: Transforming Drug Development for Neurological Disorders: Proceedings from a Multidisease Area Workshop
|
Stephenson, Diane
|
|
|
20 |
6 |
p. 1893
|
artikel
|
| 15 |
Cyclosporine as Therapy for Traumatic Brain Injury
|
Hansson, Magnus J.
|
|
|
20 |
6 |
p. 1482-1495
|
artikel
|
| 16 |
Cyclosporine as Therapy for Traumatic Brain Injury
|
Hansson, Magnus J.
|
|
|
20 |
6 |
p. 1482-1495
|
artikel
|
| 17 |
Dihydromyricetin Alleviates Ischemic Brain Injury by Antagonizing Pyroptosis in Rats
|
Ding, Huiru
|
|
|
20 |
6 |
p. 1847-1858
|
artikel
|
| 18 |
Dihydromyricetin Alleviates Ischemic Brain Injury by Antagonizing Pyroptosis in Rats
|
Ding, Huiru
|
|
|
20 |
6 |
p. 1847-1858
|
artikel
|
| 19 |
D1R-5-HT2AR Uncoupling Reduces Depressive Behaviours via HDAC Signalling
|
Li, Weifen
|
|
|
20 |
6 |
p. 1875-1892
|
artikel
|
| 20 |
D1R-5-HT2AR Uncoupling Reduces Depressive Behaviours via HDAC Signalling
|
Li, Weifen
|
|
|
20 |
6 |
p. 1875-1892
|
artikel
|
| 21 |
Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY)
|
Chisari, Clara G.
|
|
|
20 |
6 |
p. 1696-1706
|
artikel
|
| 22 |
Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY)
|
Chisari, Clara G.
|
|
|
20 |
6 |
p. 1696-1706
|
artikel
|
| 23 |
Evolving Therapeutic Options for the Treatment of Duchenne Muscular Dystrophy
|
D'Ambrosio, Eleonora S.
|
|
|
20 |
6 |
p. 1669-1681
|
artikel
|
| 24 |
Evolving Therapeutic Options for the Treatment of Duchenne Muscular Dystrophy
|
D’Ambrosio, Eleonora S.
|
|
|
20 |
6 |
p. 1669-1681
|
artikel
|
| 25 |
Frequency-Dependent Reduction of Cybersickness in Virtual Reality by Transcranial Oscillatory Stimulation of the Vestibular Cortex
|
Benelli, Alberto
|
|
|
20 |
6 |
p. 1796-1807
|
artikel
|
| 26 |
Frequency-Dependent Reduction of Cybersickness in Virtual Reality by Transcranial Oscillatory Stimulation of the Vestibular Cortex
|
Benelli, Alberto
|
|
|
20 |
6 |
p. 1796-1807
|
artikel
|
| 27 |
Functional Brain Networks to Evaluate Treatment Responses in Parkinson's Disease
|
Barbero, János A.
|
|
|
20 |
6 |
p. 1653-1668
|
artikel
|
| 28 |
Functional Brain Networks to Evaluate Treatment Responses in Parkinson’s Disease
|
Barbero, János A.
|
|
|
20 |
6 |
p. 1653-1668
|
artikel
|
| 29 |
Glibenclamide for Brain Contusions: Contextualizing a Promising Clinical Trial Design that Leverages an Imaging-Based TBI Endotype
|
Jha, Ruchira M.
|
|
|
20 |
6 |
p. 1472-1481
|
artikel
|
| 30 |
Glibenclamide for Brain Contusions: Contextualizing a Promising Clinical Trial Design that Leverages an Imaging-Based TBI Endotype
|
Jha, Ruchira M.
|
|
|
20 |
6 |
p. 1472-1481
|
artikel
|
| 31 |
Gys1 Antisense Therapy Prevents Disease-Driving Aggregates and Epileptiform Discharges in a Lafora Disease Mouse Model
|
Donohue, Katherine J.
|
|
|
20 |
6 |
p. 1808-1819
|
artikel
|
| 32 |
Gys1 Antisense Therapy Prevents Disease-Driving Aggregates and Epileptiform Discharges in a Lafora Disease Mouse Model
|
Donohue, Katherine J.
|
|
|
20 |
6 |
p. 1808-1819
|
artikel
|
| 33 |
HMG-CoA Reductase Inhibitors for Traumatic Brain Injury
|
Katlowitz, Kalman
|
|
|
20 |
6 |
p. 1538-1545
|
artikel
|
| 34 |
HMG-CoA Reductase Inhibitors for Traumatic Brain Injury
|
Katlowitz, Kalman
|
|
|
20 |
6 |
p. 1538-1545
|
artikel
|
| 35 |
Increasing Rigor of Preclinical Research to Maximize Opportunities for Translation
|
Radabaugh, Hannah L.
|
|
|
20 |
6 |
p. 1433-1445
|
artikel
|
| 36 |
Increasing Rigor of Preclinical Research to Maximize Opportunities for Translation
|
Radabaugh, Hannah L.
|
|
|
20 |
6 |
p. 1433-1445
|
artikel
|
| 37 |
Interleukin-1 Receptor Antagonist as Therapy for Traumatic Brain Injury
|
Lindblad, Caroline
|
|
|
20 |
6 |
p. 1508-1528
|
artikel
|
| 38 |
Interleukin-1 Receptor Antagonist as Therapy for Traumatic Brain Injury
|
Lindblad, Caroline
|
|
|
20 |
6 |
p. 1508-1528
|
artikel
|
| 39 |
Intravenous Administration of an AAV9 Vector Ubiquitously Expressing C1orf194 Gene Improved CMT-Like Neuropathy in C1orf194 -/- Mice
|
Shen, Zongrui
|
|
|
20 |
6 |
p. 1835-1846
|
artikel
|
| 40 |
Intravenous Administration of an AAV9 Vector Ubiquitously Expressing C1orf194 Gene Improved CMT-Like Neuropathy in C1orf194-/- Mice
|
Shen, Zongrui
|
|
|
20 |
6 |
p. 1835-1846
|
artikel
|
| 41 |
Letter from the Editor-in-Chief: Neurotherapeutics' Transition to Gold Open Access
|
Mouradian, M. Maral
|
|
|
20 |
6 |
p. 1427
|
artikel
|
| 42 |
Letter from the Editor-in-Chief: Neurotherapeutics’ Transition to Gold Open Access
|
Mouradian, M. Maral
|
|
|
20 |
6 |
p. 1427
|
artikel
|
| 43 |
Magnetic Resonance-Guided Focused Ultrasound Thalamotomy Rebalances Atypical Functional Hierarchy in Patients with Essential Tremor
|
Lin, Jiaji
|
|
|
20 |
6 |
p. 1755-1766
|
artikel
|
| 44 |
Magnetic Resonance-Guided Focused Ultrasound Thalamotomy Rebalances Atypical Functional Hierarchy in Patients with Essential Tremor
|
Lin, Jiaji
|
|
|
20 |
6 |
p. 1755-1766
|
artikel
|
| 45 |
Management Strategies Based on Multi-Modality Neuromonitoring in Severe Traumatic Brain Injury
|
Lazaridis, Christos
|
|
|
20 |
6 |
p. 1457-1471
|
artikel
|
| 46 |
Management Strategies Based on Multi-Modality Neuromonitoring in Severe Traumatic Brain Injury
|
Lazaridis, Christos
|
|
|
20 |
6 |
p. 1457-1471
|
artikel
|
| 47 |
N-Acetylcysteine and Probenecid Adjuvant Therapy for Traumatic Brain Injury
|
Clark, Robert S.B.
|
|
|
20 |
6 |
p. 1529-1537
|
artikel
|
| 48 |
N-Acetylcysteine and Probenecid Adjuvant Therapy for Traumatic Brain Injury
|
Clark, Robert S. B.
|
|
|
20 |
6 |
p. 1529-1537
|
artikel
|
| 49 |
Neurosteroid Receptor Modulators for Treating Traumatic Brain Injury
|
Verdoorn, Todd A.
|
|
|
20 |
6 |
p. 1603-1615
|
artikel
|
| 50 |
Neurosteroid Receptor Modulators for Treating Traumatic Brain Injury
|
Verdoorn, Todd A.
|
|
|
20 |
6 |
p. 1603-1615
|
artikel
|
| 51 |
Optimized Nutrition in Mitochondrial Disease Correlates to Improved Muscle Fatigue, Strength, and Quality of Life
|
DiVito, Donna
|
|
|
20 |
6 |
p. 1723-1745
|
artikel
|
| 52 |
Optimized Nutrition in Mitochondrial Disease Correlates to Improved Muscle Fatigue, Strength, and Quality of Life
|
DiVito, Donna
|
|
|
20 |
6 |
p. 1723-1745
|
artikel
|
| 53 |
Optimized Nutrition in Mitochondrial Diseases Correlates with Improved Muscle Fatigue, Strength, and Quality of Life: You Are What You Eat, or Are You?
|
Saneto, Russell P.
|
|
|
20 |
6 |
p. 1694-1695
|
artikel
|
| 54 |
Optimized Nutrition in Mitochondrial Diseases Correlates with Improved Muscle Fatigue, Strength, and Quality of Life: You Are What You Eat, or Are You?
|
Saneto, Russell P.
|
|
|
20 |
6 |
p. 1694-1695
|
artikel
|
| 55 |
Paradigm Shift: Multiple Potential Pathways to Neurodegenerative Dementia
|
Perna, Amalia
|
|
|
20 |
6 |
p. 1641-1652
|
artikel
|
| 56 |
Paradigm Shift: Multiple Potential Pathways to Neurodegenerative Dementia
|
Perna, Amalia
|
|
|
20 |
6 |
p. 1641-1652
|
artikel
|
| 57 |
Persistent NRG1 Type III Overexpression in Spinal Motor Neurons Has No Therapeutic Effect on ALS-Related Pathology in SOD1G93A Mice
|
Hernández, Sara
|
|
|
20 |
6 |
p. 1820-1834
|
artikel
|
| 58 |
Persistent NRG1 Type III Overexpression in Spinal Motor Neurons Has No Therapeutic Effect on ALS-Related Pathology in SOD1G93A Mice
|
Hernández, Sara
|
|
|
20 |
6 |
p. 1820-1834
|
artikel
|
| 59 |
Pharmacotherapy for Traumatic Brain Injury: The Next Generation of Clinical Trials
|
Diaz-Arrastia, Ramon
|
|
|
20 |
6 |
p. 1428-1432
|
artikel
|
| 60 |
Pharmacotherapy for Traumatic Brain Injury: The Next Generation of Clinical Trials
|
Diaz-Arrastia, Ramon
|
|
|
20 |
6 |
p. 1428-1432
|
artikel
|
| 61 |
Phosphodiesterase-5 (PDE-5) Inhibitors as Therapy for Cerebrovascular Dysfunction in Chronic Traumatic Brain Injury
|
Kalyani, Priyanka
|
|
|
20 |
6 |
p. 1629-1640
|
artikel
|
| 62 |
Phosphodiesterase-5 (PDE-5) Inhibitors as Therapy for Cerebrovascular Dysfunction in Chronic Traumatic Brain Injury
|
Kalyani, Priyanka
|
|
|
20 |
6 |
p. 1629-1640
|
artikel
|
| 63 |
Recombinant Erythropoietin Induces Oligodendrocyte Progenitor Cell Proliferation After Traumatic Brain Injury and Delayed Hypoxemia
|
Shumilov, Kirill
|
|
|
20 |
6 |
p. 1859-1874
|
artikel
|
| 64 |
Recombinant Erythropoietin Induces Oligodendrocyte Progenitor Cell Proliferation After Traumatic Brain Injury and Delayed Hypoxemia
|
Shumilov, Kirill
|
|
|
20 |
6 |
p. 1859-1874
|
artikel
|
| 65 |
Retraction Note: Deferiprone Treatment in Aged Transgenic Tau Mice Improves Y-Maze Performance and Alters Tau Pathology
|
Rao, Shalini S.
|
|
|
20 |
6 |
p. 1894
|
artikel
|
| 66 |
Retraction Note: Deferiprone Treatment in Aged Transgenic Tau Mice Improves Y-Maze Performance and Alters Tau Pathology
|
Rao, Shalini S.
|
|
|
20 |
6 |
p. 1894
|
artikel
|
| 67 |
Retraction Note: Mechanisms Involved in Superiority of Angiotensin Receptor Blockade over ACE Inhibition in Attenuating Neuropathic Pain Induced in Rats
|
Hegazy, Nora
|
|
|
20 |
6 |
p. 1895
|
artikel
|
| 68 |
Retraction Note: Mechanisms Involved in Superiority of Angiotensin Receptor Blockade over ACE Inhibition in Attenuating Neuropathic Pain Induced in Rats
|
Hegazy, Nora
|
|
|
20 |
6 |
p. 1895
|
artikel
|
| 69 |
Should Age 65 be a cutoff for Primary Progressive Multiple Sclerosis therapy? Real World Data is Critical
|
Coyle, P.K.
|
|
|
20 |
6 |
p. 1692-1693
|
artikel
|
| 70 |
Should Age 65 be a cutoff for Primary Progressive Multiple Sclerosis therapy? Real World Data is Critical
|
Coyle, P. K.
|
|
|
20 |
6 |
p. 1692-1693
|
artikel
|
| 71 |
Therapeutic Effects of Combination of Nebivolol and Donepezil: Targeting Multifactorial Mechanisms in ALS
|
Lee, Soo Yeon
|
|
|
20 |
6 |
p. 1779-1795
|
artikel
|
| 72 |
Therapeutic Effects of Combination of Nebivolol and Donepezil: Targeting Multifactorial Mechanisms in ALS
|
Lee, Soo Yeon
|
|
|
20 |
6 |
p. 1779-1795
|
artikel
|
| 73 |
The Renin Angiotensin System as a Therapeutic Target in Traumatic Brain Injury
|
Villapol, Sonia
|
|
|
20 |
6 |
p. 1565-1591
|
artikel
|
| 74 |
The Renin Angiotensin System as a Therapeutic Target in Traumatic Brain Injury
|
Villapol, Sonia
|
|
|
20 |
6 |
p. 1565-1591
|
artikel
|
| 75 |
Transforming Drug Development for Neurological Disorders: Proceedings from a Multidisease Area Workshop
|
Stephenson, Diane
|
|
|
20 |
6 |
p. 1682-1691
|
artikel
|
| 76 |
Transforming Drug Development for Neurological Disorders: Proceedings from a Multidisease Area Workshop
|
Stephenson, Diane
|
|
|
20 |
6 |
p. 1682-1691
|
artikel
|
| 77 |
Treating Traumatic Brain Injury with Minocycline
|
Bergold, Peter J.
|
|
|
20 |
6 |
p. 1546-1564
|
artikel
|
| 78 |
Treating Traumatic Brain Injury with Minocycline
|
Bergold, Peter J.
|
|
|
20 |
6 |
p. 1546-1564
|
artikel
|
| 79 |
Wavelet-Based Bracketing, Time–Frequency Beta Burst Detection: New Insights in Parkinson's Disease
|
Sil, Tanmoy
|
|
|
20 |
6 |
p. 1767-1778
|
artikel
|
| 80 |
Wavelet-Based Bracketing, Time–Frequency Beta Burst Detection: New Insights in Parkinson’s Disease
|
Sil, Tanmoy
|
|
|
20 |
6 |
p. 1767-1778
|
artikel
|
Tijdschrift beschrijving